NCT02506361View on ClinicalTrials.gov

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2025

Study Completion Date

October 31, 2025

Conditions

Breast Cancer

Trial Locations (1)

300060

RECRUITING

Jin Zhang, Tianjin

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT02506361 - Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter